EXANE DERIVATIVES - ATRECA INC ownership

ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 98 filers reported holding ATRECA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of ATRECA INC
ValueSharesWeighting
Q4 2020$130,292,000
+15.6%
8,0680.0%0.04%
+15.2%
Q3 2020$112,704,000
+24.0%
8,068
+88.9%
0.03%
+37.5%
Q2 2020$90,860,000
+28.6%
4,2700.0%0.02%
+20.0%
Q1 2020$70,665,0004,2700.02%
Other shareholders
ATRECA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 912,642$237,2870.28%
CM Management, LLC 350,000$91,3500.10%
Aisling Capital Management LP 387,653$101,1770.04%
Boxer Capital, LLC 2,202,333$574,8090.03%
Baker Brothers Advisors 3,532,760$922,0500.01%
Redmile Group, LLC 442,653$115,5320.01%
Rock Springs Capital Management LP 362,530$94,6200.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 150,000$39,1500.00%
ERn Financial, LLC 21,702$5,6640.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
View complete list of ATRECA INC shareholders